Finance

Lists
Why is 603079 up 3.34%?
Dive Deeper
603079:SHA
Zhejiang Shengda Bio-pharm Co Ltd
CN¥13.61
+3.34%
(+0.44) 1D
Sep 30, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603079...
Open
CN¥13.20
High
CN¥13.86
Low
CN¥13.17
Mkt. cap
2.57B
Avg. vol.
9.82M
Volume
7.63M
Dividend
0.73%
Quarterly dividend
CN¥0.03
Ex-dividend date
Jul 1, 2026
P/E ratio
56.37
52-wk high
CN¥22.00
52-wk low
CN¥9.94
EPS
CN¥0.24
Shares outstanding
112.00M
No. of employees
1K
Open
CN¥13.20
High
CN¥13.86
Low
CN¥13.17
Mkt. cap
2.57B
Avg. vol.
9.82M
Volume
7.63M
Dividend
0.73%
Quarterly dividend
CN¥0.03
Ex-dividend date
Jul 1, 2026
P/E ratio
56.37
52-wk high
CN¥22.00
52-wk low
CN¥9.94
EPS
CN¥0.24
Shares outstanding
112.00M
No. of employees
1K
News stories
From web sources and news partners
About Zhejiang Shengda Bio-pharm Co Ltd
CEO-
Employees1.08K
FoundedFeb 8, 1999
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Jun 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
197.50M
223.25M
189.22M
199.84M
Cost of goods sold
145.85M
175.36M
136.99M
144.97M
Cost of revenue
145.85M
175.36M
136.99M
144.97M
Research and development expenses
12.85M
18.11M
10.09M
13.69M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
20.54M
22.59M
20.29M
21.99M
Operating expense
33.73M
48.77M
31.77M
39.22M
Total operating expenses
179.59M
224.13M
168.75M
184.19M
Operating income
17.92M
-879.22K
20.46M
15.65M
Other non operating income
-503.85K
283.41K
-3.83M
3.63M
EBT including unusual items
22.53M
8.03M
18.58M
13.30M
EBT excluding unusual items
19.23M
-279.90K
19.37M
13.02M
Income tax expense
5.45M
-2.51M
3.27M
4.09M
Effective tax rate
24.20%
-31.26%
17.59%
30.77%
Other operating expenses
1.31M
7.99M
1.54M
3.51M
Net income
16.10M
8.82M
13.17M
7.35M
Net profit margin
8.15%
3.95%
6.96%
3.68%
Earnings per share
-
-
-
-
Interest and investment income
1.24M
2.80M
2.86M
3.33M
Interest expense
-178.48K
-45.11K
-115.42K
-1.93M
Net interest expenses
1.06M
2.75M
2.74M
1.40M
Depreciation and amortization charges
-
-
-
-
EBITDA
35.88M
17.98M
39.32M
36.53M
Gain or loss from assets sale
86.18K
477.31K
-
563.49K
AI content may include mistakes. Learn more
Google apps